When does Sun Pharmaceuticals Industries Ltd. usually announce its dividend?
- Answer Field
-
The company typically announces interim dividends in January and final dividends in May.
BAJAJ BROKING
Introduction
Sun Pharmaceuticals Industries Ltd. is one of India’s largest and most respected pharmaceutical companies, with a strong global presence. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments. The company has a solid reputation for innovation, quality, and compliance, contributing to its consistent growth over the years.
Apart from its operational performance, Sun Pharma also focuses on rewarding its shareholders. It has a history of consistent dividend declarations, reflecting its commitment to delivering value. This article explores the company's dividend yield, payout patterns, dividend policy, and guidance for shareholders to check or claim dividends.
Year | Dividend Per Share (₹) | Payout (%) |
2024 | 13.50 | 34 |
2023 | 11.50 | 33 |
2022 | 10.00 | 73 |
2021 | 7.50 | 62 |
2020 | 4.00 | 25 |
2019 | 2.75 | 25 |
Sun Pharmaceuticals has maintained a dividend policy that aligns with its profitability and operational strength. As of March 2024, the company declared a dividend of ₹13.50 per share. The basic earnings per share (EPS) during the same period stood at ₹11.06. While the dividend yield varies with market price movements, the company’s payout trends indicate a steady commitment to rewarding shareholders.
The dividend payout ratio was around 34%, which signifies that a moderate portion of earnings was returned to shareholders while the rest was retained for business expansion and reserves. Sun Pharma’s financial performance over the years continues to support its ability to declare consistent dividends without compromising long-term growth.
Sun Pharmaceuticals follows a balanced and transparent dividend policy. The primary factors influencing this policy include the company's profitability, availability of free cash flows, and future business expansion needs. With a dividend payout ratio of 46.6%, the company signals a healthy approach—rewarding shareholders while retaining funds for research, development, and strategic acquisitions.
The management also considers market conditions, capital expenditure plans, and regulatory obligations when finalising the dividend. This dynamic and responsive strategy ensures that dividends are sustainable, financially viable, and aligned with shareholder expectations. As a result, Sun Pharma has built a reputation for responsible dividend distribution supported by sound financial principles.
Shareholders can check dividend announcements and payment statuses through the company's official website or financial news portals. Dividends are typically credited directly to the shareholder's registered bank account. If dividends are not received, shareholders should contact the company's investor relations department or their respective brokerage firm.
Sun Pharmaceuticals Industries Ltd. has consistently rewarded shareholders through dividend declarations, with a payout ratio of 46.6% reflecting both profitability and fiscal prudence. The company’s ability to generate returns while maintaining robust R&D and global expansion underscores its financial strength and investor focus.
For potential and existing investors, analysing Sun Pharma’s dividend history alongside its earnings, growth trajectory, and market conditions can offer insights into future returns. While dividend income is a valuable component, it should be assessed within the broader context of total returns and business sustainability before making investment decisions.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer
Share this article:
No result found
The company typically announces interim dividends in January and final dividends in May.
As of April 2, 2025, the dividend yield is approximately 0.79%.
Specific comparative data is not provided in the available information. Investors may consult financial analysts or conduct independent research for comparisons.
Dividends are usually credited to the shareholder's registered bank account. Shareholders can verify receipt through their bank statements or by contacting the company's investor relations department.
The company has maintained a dividend payout ratio of 46.6%, indicating a consistent approach to dividend distribution.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading